20506 ⎘
Medicinal preparations containing organic active ingredients; Phosphorus compounds; Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
HIV INHIBITOR COMPOUNDS
#2BIPHASIC CHRONO-ADAPTIVE NUTRACEUTICAL SYSTEM FOR ENHANCED CIRCADIAN BIOAVAILABILITY
#3PARENTERAL NUTRITION FORMULATION
#4LONG-ACTING LIPOSOMAL COMPOSITION FOR TREATMENT OF PAIN IN ARTICULAR DISORDERS
#5SYSTEMS AND METHODS FOR EPICARDIAL TISSUE DISTENSION SOLUTIONS
#6PHARMACEUTICAL PREPARATION FOR INTRANASAL ADMINISTRATION AND PREPARATION METHOD THEREFOR
#7Composition for Improving Cognitive Function
#8CANNABINOID FORMULATIONS
#9Nutritional composition for stroke
#10MAGNESIUM-L-THREONATE AND NEUROTRANSMITTER COMPOSITIONS AND RELATED METHODS
#11UROLITHIN COMBINATIONS
#12COMPOSITION AND APPLICATION THEREOF
#13Mind and Body Healing Synergistic Phytomedical Formulation
#14COMPOSITIONS WITH IMPROVED SOLUBILITY OF POOR-WATER-SOLUBLE AGENTS AND METHODS OF MAKING
#15Therapeutic use of hydrogen sulfide in frostbite injury
#16METHOD AND COMPOSITION FOR TREATING, ALLEVIATING OR PREVENTING A DISEASE OR CONDITION CAUSED BY AIR POLLUTANT
#17METHOD OF ADMINISTRATION AND TREATMENT
#18EXOSOME SYSTEMS, PRODUCTS AND METHODS
#19SLEEP-IMPROVING COMPOSITIONS AND METHODS OF USE
#20MULTIVITAMIN FOR ADJUVANT TREATMENT OF TUMOR, AND PREPARATION METHOD AND APPLICATION THEREOF
#21COMPOSITION FOR LOCALIZED FAT REDUCTION WITHOUT PAIN, EDEMA AND SIDE EFFECTS AND METHOD OF ADMINISTRATION THEREOF
#22OXYGEN-ENHANCED ADAPTIVE FUNCTIONAL BEVERAGE FOR ANTI-AGING AND METHOD OF PREPARATION
#23PORE IMPROVING AGENT AND SKIN IMPROVING AGENT
#24EXOSOME SYSTEMS, PRODUCTS AND METHODS
#25NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT
#26Combination of Broadly Neutralizing HIV Antibodies and Viral Inducers
#27METHODS FOR TREATING LENTIVIRUS INFECTION
#28GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF
#29ASHWAGANDHA EXTRACTS AND FORMULATIONS THEREOF
#30IMMUNOMODULATORY LIPIDS AND USES THEREOF
#31COMPOSITIONS FOR VITAMIN D PRODUCTION
#32SLEEP-IMPROVING COMPOSITIONS AND METHODS OF USE
#33COMPOSITION COMPRISING A MIXTURE OF DHA AND/OR EPA AND A PHOSPHOLIPID OF PLANT ORIGIN
#34LONG-ACTING LIPOSOMAL COMPOSITION FOR TREATMENT OF PAIN IN ARTICULAR DISORDERS
#35LIPOSOMAL FORMULATION FOR JOINT LUBRICATION
#36COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS
#37LYSOPHOSPHATIDYLSERINE ANALOGUE, AND LYSOPHOSPHATIDYLSERINE ANALOGUE-CONTAINING PHAMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING FIBROSIS
#38LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS
#39DOSAGE REGIMENS FOR TREATMENT OF DENGUE INFECTION
#40NATURAL DIETARY SUPPLEMENT FOR MENTAL HEALTH
#41STEROIDS AND ANTIBODY-CONJUGATES THEREOF
#42MEDICINE FOR STEATOHEPATITIS
#43HIV INHIBITOR COMPOUNDS
#44NOVEL PLASMALOGEN DERIVATIVE
#45LIPID EMULSIONS FOR PARENTERAL NUTRITION
#46LYSOPHOSPHATIDYLCHOLINE COMBINATIONS AS A THERAPY TO TREAT CARDIAC ARREST
#47SYSTEMS AND METHODS FOR TREATMENT OF HEARING USING DIHEXA
#48COMPOSITION FOR LIVING BODY
#49COMPOSITION FOR LIVING BODY
#50PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE COMPRISING LYSOPHOSPHOLIPID
#51NUTRITIONAL COMPOSITION FOR IMPROVING SLEEP
#52METHODS FOR INCREASING FAT ABSORPTION
#53NATURAL CLUSTER OR FORMULATION CONTAINING BIXA ORELLANA OIL WITH A STANDARDIZED TOCOTRIENOL CONTENT, DRY MYRCIARIA DUBIA EXTRACT WITH A STANDARDIZED ASCORBIC ACID CONTENT AND SOY GERM WITH A STANDARDIZED ISOFLAVONE CONTENT, METHOD FOR PREPARING SAME AND USE THEREOF FOR THE SUPPORT TREATMENT OF MENOPAUSE SYMPTOMS
#54COMPOSITIONS COMPRISING AN AMERICAN CRANBERRY EXTRACT AND PHOSPHOLIPIDS
#55Irak Inhibitor for Treating Cytokine Release-Related Conditions Associated With Infection by a Respiratory Virus
#56Sleep-improving compositions and methods of use
#57LIPID EMULSION FOR PARENTERAL NUTRITION COMPRISING GPC
#58TREATMENT OF SCHIZOPHRENIA WITH PDK1 INHIBITION BY COMBINING PDK1 INHIBITORS WITH LIPID REPLACEMENT THERAPY
#59AMIDE COMPOUND AND USE THEREOF
#60MICROSCALE THERMOPHORESIS TO EVALUATE CHANNEL LIPID INTERACTIONS AND METHODS OF TREATING NAV CHANNELS RELATED DISEASES
#61SYSTEMS AND METHODS FOR DELIVERY OF HUMANIN OR OTHER PEPTIDES
#62COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY CONDITIONS
#63STEROIDS AND ANTIBODY-CONJUGATES THEREOF
#64REAGENTS AND METHODS FOR PROMOTING ARTERIAL ENDOTHELIUM DIFFERENTIATION AND NITRIC OXIDE PRODUCTION
#65COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE
#66CAPSID INHIBITORS FOR THE TREATMENT OF HIV
#67KETOAMIDE DERIVATIVE AND APPLICATION THEREOF
#68A FOOD SUPPLEMENT FOR USE AS COADJUVANT IN THE PREVENTION AND TREATMENT OF COGNITIVE DECLINE ASSOCIATED WITH ALZHEIMER DISEASE
#69METHODS OF CREATING A SLURRY USING LIPOSOME EMULSIONS
#70COMPOSITIONS AND METHODS FOR TREATING DEPRESSION
#71COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS
#72METHOD FOR IMPROVING COGNITIVE FUNCTION AND A DIETARY SUPPLEMENT FOR USE IN THE METHOD
#73COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS
#74BROMELAIN PROTEASE, BROMELAIN, JACALIN-LIKE LECTIN, EXTRACT FROM THE STEM AND/OR THE FRUIT OF A PINEAPPLE PLANT, COMBINATION PREPARATION, BROMELAIN PROTEASE INHIBITOR, PROTEIN/PROTEASE MIX, AND GLYCATED BROMELAIN PROTEIN FORMED BY EXOGENOUS NON-ENZYMATIC GLYCATION, FOR USE IN THE TREATMENT OR PROPHYLAXIS OF VIRUS INFECTIONS CAUSED BY CORONAVIRUSES IN A HUMAN OR ANIMAL
#75RECONSTITUTED HIGH DENSITY LIPOPROTEIN TREATMENT OF MYOCARDIAL INFARCTION
#76BIOEFFECTIVE KRILL OIL COMPOSITIONS
#77PHOSPHOLIPID COMPOUNDS AND FORMULATIONS
#78BRUISING AND FILLER COMPOSITIONS AND METHODS FOR USE
#79EXOSOME SYSTEMS, PRODUCTS AND METHODS
#80Anti Viral Therapy
#81LYMPH-RELEASING COMPOSITIONS OF FATTY ACIDS AND USES THEREOF FOR LYMPHATIC INCORPORATION AND SYSTEMIC DISEASE TREATMENT
#82Systems and methods for delivery of humanin or other peptides
#83COMPOSITION FOR AMELIORATING INFLAMMATION OF PERIODONTAL TISSUE
#84ANTI-VIRAL AGENT
#85TREATMENT OF CYTOKINE RELEASE SYNDROME WITH GM-CSF ANTAGONISTS
#86METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT AND SKIN TIGHTENING
#87COMPOSITION FOR HYDRATION AND REDUCING THE EFFECTS OF ACOHOL
#88COMPOSITION FOR IMPROVING COGNITIVE FUNCTION, AGENT FOR IMPROVING COGNITIVE FUNCTION, AND FOOD FOR IMPROVING COGNITIVE FUNCTION
#89Compositions and Methods for Altering Tissue Specificity and Improving AAV9-Mediated Gene Transfer
#90LIPID COMPOSITIONS
#91DELIVERY METHODS FOR OMEGA-3'S AND COMPOSITIONS FOR VITAMINS AND MINERALS USED TO ENHANCE VISUAL ACUITY AND MENTAL DEVELOPMENT IN THE HUMAN BODY
#92NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT
#93Composition of matter, system, and method for enhanced magnesium uptake, retention, and synergistic actions
#94Non medicated lotion to correct erectile dysfunction
#95PRECISION CANNABINOID THERAPY FORMULATIONS AND METHODS OF USE
#96COMPOSITION FOR INHIBITING DIABETES MELLITUS AND METHOD OF MANUFACTURING THE SAME
#97Method of administration and treatment
#98COMPOSITION FOR EXTERNAL USE ON SKIN FOR INFLAMMATORY DISEASES
#99LUNG TREATMENT COMPOSITIONS
#100Topical compositions designated to maintain and/or restore the integrity of the mucosa and damaged epidermis
#101INHALATION FORMULATIONS OF 1`-CYANO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS
#102COMPOSITIONS AND METHODS FOR INVASIVE AND NON-INVASIVE PROCEDURAL SKINCARE
#103SURFACTANT FORMULATIONS FOR INHALATION
#104USE OF PHOSPHATIDYLSERINE IN PREPARATION OF DRUG FOR TREATING INFLAMMATORY BOWEL DISEASE
#105Treatment of Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy with N-Acetylcysteine Amide (NACA) or (2R,2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide)(DiNACA)
#106KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA
#107BRAIN HEALTH SUPPLEMENTS
#108PARENTERAL NUTRITION FORMULATION AND METHODS OF PREPARATION THEREOF
#109BLOOD PLASMA-CONTAINING COMPOSITIONS
#110METHODS FOR TREATING SARS COV-2 INFECTIONS
#111INTELLIGENT DELIVERY OF INGESTED AND ABSORBED MOLECULES
#112PHOSPHOLIPID BILAYERS CATALYTICALLY PROMOTE PROTEIN REFOLDING, INHIBIT AND REVERSE PROTEIN AGGREGATE FORMATION, AND METHODS OF TREATING NEURODEGENERATIVE DISEASES USING THE SAME
#113INFANT FORMULA MILK POWDER RICH IN MILK FAT GLOBULE MEMBRANE PROTEIN, PHOSPHOLIPIDS AND OLIGOSACCHARIDES AND PREPARATION METHOD THEREFOR
#114Glycophospholipid polymeric network and use thereof
#115Phospholipid compounds and uses thereof
#116ISOTONIC LIPID EMULSION
#117Orally-bioavailable nucleoside analogs
#118COMPOSITIONS FOR SUPPLEMENTING PRODUCTS WITH THERAPEUTIC AGENTS AND METHODS OF USE THEREOF
#119PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL AND BACTERIAL PNEUMONIA AND SEPSIS
#120METHODS AND SYSTEMS FOR PREDICTING ARDS
#121COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS
#122METHODS OF TREATMENT
#123NANOSYSTEMS AS SELECTIVE VEHICLES
#124Enhanced caffeinated beverage composition
#125ETHANOLAMINE-BASED LIPID BIOSYNTHETIC COMPOUNDS, METHOD OF MAKING AND USE THEREOF
#126TREATING MICROVASCULAR DYSFUNCTION
#127COMPOSITION FOR ENHANCING IMMUNE FUNCTION
#128OLEYL PHOSPHOCHOLINE CONTAINING GRANULATES
#129Theacrine-based supplement and method of use thereof in a synergistic combination with caffeine
#130NUTRITIONAL FORMULA
#131CANCER THERAPEUTIC METHOD
#132DIETARY SUPPLEMENT FOR IMPROVING BRAIN PERFORMANCE
#133TRACELESS LINKERS AND PROTEIN-CONJUGATES THEREOF
#134NEUTRAL ENDOPEPTIDASE (NEP) AND HUMAN SOLUBLE ENDOPEPTIDASE (hSEP) INHIBITORS FOR PROPHYLAXIS AND TREATMENT OF EYE DISEASES
#135TOPICAL COMPOSITIONS DESIGNATED TO MAINTAIN AND/OR RESTORE THE INTEGRITY OF THE MUCOSA AND DAMAGED EPIDERMIS
#136COMPOSITIONS AND METHODS FOR MANAGING DISORDERS
#137NUTRITIONAL COMPOSITIONS CONTAINING PHOSPHATIDYLSERINE POWDER
#138Methods and products for treating subjects with autism spectrum disorders
#139COMPOSITION AND METHOD FOR MODULATING HYDROGEN ION PHYSIOLOGY RELATED TO BRAIN HEALTH COMPONENT
#140Application of microbiota-derived plasmalogens to Treatment of Colon Cancer
#141HEMP EXTRACT FOR TREATMENT OF PAIN, CANCER AND EPILEPSY IN ANIMALS
#142LIQUID CRYSTALLINE STRUCTURE-FORMING OMEGA-3-FATTY ACID COMPOSITION
#143COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION AND WOUND HEALING
#144EDIBLE COMPOSITION FOR ALLEVIATING VISUAL FATIGUE
#145ANTI-INFLAMMATORY PROPERTIES OF MARINE LIPID COMPOSITIONS
#146DERMATOLOGICAL COLLAR FOR NON-HUMAN ANIMALS
#147COMPOSITIONS COMPRISING POLAR LIPIDS FOR MAINTAINING OR INCREASING MOBILITY AND VITALITY
#148DIRECT APPLICATION SYSTEM AND METHOD FOR THE DELIVERY OF BIOACTIVE COMPOSITIONS AND FORMULATIONS
#149HIV inhibitor compounds
#150Orally-bioavailable nucleoside analogs
#151HONOKIOL BASED COMPOSITIONS AND METHODS FOR REDUCING CORTISOL LEVELS
#152SYNOVIAL FLUID SUBSTITUTES
#153OMEGA-3 COMPOSITIONS
#154COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A N-3 FATTY ACID FOR THE PREVENTION OR TREATMENT OF MASTITIS
#155METHOD FOR PREVENTING OR TREATING GASTROINTESTINAL DISTRESS IN HUMANS USING MASTIC GUM COMPOSITIONS
#156PHOSPHOLIPID FORMULATIONS OF 1'-CYANO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS
#157Natural drugs for the treatment of inflammation and melanoma
#158COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A NUTRIENT AND/OR MINERAL FOR THE PREVENTION OR TREATMENT OF MASTITIS
#159Phospholipid compositions
#160METHODS USING PHOSPHATIDYLSERINE POWDER
#161Compositions and methods for treating dry eye
#162Method of treating urolithiasis
#163Compositions and methods for the treatment and prophylaxis of surgical site infections
#164COMPOSITIONS AND METHODS FOR DIETARY MANAGEMENT OF IMMUNE HEALTH
#165Methods of manufacturing microspheres
#166METHODS AND COMPOSITIONS FOR USE OF GROWTH FACTOR ANTIBODIES IN COMBINATION WITH NON-TYROSINE TARGETING KINASE INHIBITORS
#167COMPOSITION, ANTIOXIDANT AGENT, ANTISACCHARIFICATION AGENT, NEURITE OUTGROWTH PROMOTER, AND COGNITIVE FUNCTION IMPROVER
#168METHODS FOR THE PREPARATION OF RIBOSIDES
#169Methods of Treatments to Prolong Gestation and Complications of Menstruation or Gestation
#170DIETARY SUPPLEMENTS TO AMELIORATE DIETARY INADEQUACIES RELATED TO BRAIN HEALTH OR NEURODEGENERATIVE DISEASES, AND METHODS TO DESIGN DIETARY SUPPLEMENTS
#171SPREADABLE NUTRITIONAL SUPPLEMENT AND SPREADABLE MEDICINE
#172PARAXANTHINE-BASED COMPOSITIONS FOR PROMOTING WEIGHT LOSS
#173LIPOSOMIAL EYE DROPS SOLUTION AND USES THEREOF FOR THE TREATMENT OF DRY EYE SYNDROME
#174AGENT FOR PREVENTING OR TREATING MILD COGNITIVE IMPAIRMENT
#175COMPOSITIONS FOR IMPROVING BRAIN HEALTH AND MEMORY
#176ANTITHROMBOTIC COATING COMPOSITION AND ANTITHROMBOTIC COATING METHOD USING SAME
#177DDX17 AND NLRC4 TARGETING FOR INFLAMMATORY DISEASES
#178ACEFAPC FOR THE TREATMENT OF ACETYLCHOLINE-DEPENDENT DISEASES
#179USE OF CERTAIN PHOSPHATIDYLCHOLINES CONTAINING LONG CHAIN POLYUNSATURATED FATTY ACIDS AS NEUROPROTECTIVE AGENTS
#180Fatty Acid Compounds for Prevention and Treatment of Neurodegenerative Disorders
#181Exosome systems, products and methods
#182COMPOSITIONS COMPRISING CETYLATED FATTY ACIDS AND USE THEREOF IN THE TREATMENT OF ARTHRITIS AND JOINT INFLAMMATORY CONDITIONS
#183CENTRAL NERVOUS SYSTEM HEALTH SUPPLEMENT
#184COMPOSITION FOR USE IN PREVENTION OR REDUCTION OF OXIDATIVE STRESS AND NEURODEGENERATIVE DISEASES
#185N-Phenylacetyl-L-prolylglycine ethyl ester compositions and methods for using the same
#186Tablet dosage formulations of oleyl phosphocholine
#187Process for purifying LPC-DHA and/or LPC-EPA using a chromatographic stationary phase and compositions thereof
#188SYSTEM AND METHOD FOR DETECTING THERAPEUTIC AGENTS TO MONITOR ADHERENCE TO A TREATMENT REGIMEN
#189METHODS TO PROMOTE CEREBRAL BLOOD FLOW IN THE BRAIN
#190COMPOSITIONS FOR THE TREATMENT OF VIRAL PULMONARY INFECTIONS
#191OPTIMIZED NUTRIENT SALT COMPOSITION
#192Compounds and pharmaceutical uses thereof
#193Antimicrobial compositions containing free fatty acids
#194Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection
#195Phospholipid compounds and uses thereof
#196Reconstituted high density lipoprotein formulation and production method thereof
#197Process of producing concentrated therapeutic phospholipid composition from krill extracts containing high level of free fatty acids
#198INJECTABLE COMPOSITION FOR INDUCING LIPOLYSIS AND METHOD USING THE SAME
#199LIPID COMPOSITIONS WITH HIGH DHA CONTENT
#200MULTI-SUPPLEMENT COMPOSITIONS
#201Methods of treatment
#202METHODS AND COMPOSITIONS COMPRISING A 5HT RECEPTOR AGONIST FOR THE TREATMENT OF PSYCHOLOGICAL, COGNITIVE, BEHAVORIAL, AND/OR MOOD DISORDERS
#203COMBINATION THERAPY INCLUDING SAPC-DOPS FOR THE TREATMENT OF PANCREATIC CANCER
#204Methods of treatment
#205Method of administration and treatment
#206MAGNESIUM-L-THREONATE AND NEUROTRANSMITTER COMPOSITIONS AND RELATED METHODS
#207Method of administration and treatment
#208Contact lens packaging solutions
#209Contact lens packaging solutions
#210Topical Lipolysis Composition and Methods
#211Method of administration and treatment
#212CYCLOPENTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS
#213LIPID COMPOSITION COMPRISING ANTIOXIDANTS AND NATURAL POLYPHENOLS AS A NON-PHARMACOLOGICAL ALTERNATIVE FOR THE TREATMENT AND PREVENTION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
#214Method of administration and treatment
#215METHOD OF ADMINISTRATION AND TREATMENT
#216METHOD OF ADMINISTRATION AND TREATMENT
#217Phospholipid Ether Analogs for Imaging and Targeted Treatment of Pediatric Solid Tumors
#218Compositions and methods for treating virus infection
#219Vesicular Formulations for Use in the Treatment of Pain or Reduced Mobility of a Joint
#220MEDICINAL FOOD PRODUCTS AND METHODS FOR PRODUCING SAID PRODUCTS
#221BIOMATERIAL
#222Liposomal formulation for joint lubrication
#223Method for manufacturing functional material including plasmalogen
#224BLOOD PLASMA-CONTAINING COMPOSITIONS
#225USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION
#226Composition for external use on skin for inflammatory diseases
#227METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF RESPIRATORY INFECTIONS
#228Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1
#229COMPOSITIONS AND METHODS FOR THE TREATMENT OF MASTITIS
#230Lysophosphatidylcholine compositions
#231Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
#232COMPOSITIONS AND METHODS FOR TREATING CANCER
#233NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT
#234Lipid emulsion for parenteral nutrition comprising GPC
#235DELIVERY METHODS FOR OMEGA-3'S AND COMPOSITIONS FOR VITAMINS AND MINERALS USED TO ENHANCE VISUAL ACUITY AND MENTAL DEVELOPMENT IN THE HUMAN BODY
#236Method of treating eye diseases with krill oil
#237STIMULATION OF AN IMMUNE RESPONSE BY ENANTIOMERS OF CATIONIC LIPIDS
#238FORMULATIONS OF PHOSPHOLIPID COMPRISING OMEGA FATTY ACIDS
#239METHOD OF TREATING AND PREVENTING CORONAVIRUSES WITH LOW DOSAGE INTERFERON BETA-1A AS A TH17 INHIBITOR
#240Phosphate and phosphonate derivatives of 7-amino-5-thio-thiazolo[4,5-d]pyrimidines and their use in treating conditions associated with elevated levels of CX3CR1 and/or CX3CL1
#241Treatment of cytokine release syndrome with GM-CSF antagonists
#242Methods for treating SARS CoV-2 infections
#243NANOSYSTEMS AS SELECTIVE VEHICLES
#244LIPOSOMES FOR INHIBITING BIOFILM FORMATION
#245COMPOSITIONS AND METHODS FOR INHIBITING CD73
#246Compounds and pharmaceutical uses thereof
#247COMPOSITIONS COMPRISING AN AMERICAN CRANBERRY EXTRACT AND PHOSPHOLIPIDS
#248Phospholipid compounds and formulations
#249Method of Increasing Muscle Mass and Strength and Compositions Therefor
#250METHOD OF ADMINISTRATION AND TREATMENT
#251USE OF SUBSTITUTED AMINOPROPIONATE COMPOUNDS IN TREATMENT OF SARS-COV-2 INFECTION
#252PARENTERAL NUTRITION FORMULATION
#253Compositions and methods for invasive and non-invasive procedural skincare
#254Mebendazole prodrugs with enhanced solubility and oral bioavailability
#255THERAPEUTIC CANNABIS EXTRACTS
#256Methods to reduce complications of intra-articular steroid
#257COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
#258PLASMALOGEN-CONTAINING COMPOSITION
#259COMPOSITION CONTAINING PLASMALOGEN FOR ENHANCING MEMORIZATION ABILITY
#260Composition and method for treating muscle cramps containing choline alfoscerate as active ingredient
#261Method of administration and treatment
#262Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer
#263ANTIFIBROTIC COMPOSITION
#264MULTIVALENT LIGAND-LIPID CONSTRUCTS
#265Enhanced caffeinated beverage composition
#266TRICYCLIC HETEROCYCLE COMPOUNDS USEFUL AS HIV INTEGRASE INHIBITORS
#267LIPOSOMAL NANO FORMULATION OF COMBINATIONAL ANTIBIOTICS AND THE USES THEREOF
#268Therapeutic cannabis extracts
#269Lipid compositions
#270Treating Autoimmune Disorders with Acetylcholinesterase Inhibitors
#271Methods for producing compositions containing plasmalogen
#272Methods for treating virus infections
#273METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING SKIN BARRIER DISRUPTIONS
#274NEUTRAL ENDOPEPTIDASE (NEP) AND HUMAN SOLUBLE ENDOPEPTIDASE (hSEP) INHIBITORS FOR PROPHYLAXIS AND TREATMENT OF EYE DISEASES
#275Persistent topical antimicrobial compositions and methods of using the same
#276Cochleates made with soy phosphatidylserine
#277Pharmaceutical compositions
#278TREATMENT OF CANCERS HAVING DRIVING ONCOGENIC MUTATIONS
#279HYDROCARBON / LIPID - CAROTENOID COMPLEXES
#280A NOVEL SYNERGIC HERBAL FORMULATION FOR THE PREVENTION AND TREATMENT OF PRE-DIABETES, DIABETES AND OTHER INSULIN RESISTANCE CASES
#281REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#282PLANT-BASED COMPOSITIONS AND METHODS FOR REDUCING CORTISOL LEVELS
#283COMBINATION THERAPY USING ENANTIOPURE, OXY-SUBSTITUTED, DEUTERIUM-ENRICHED 5-(BENZYL)-5-DEUTERO-THIAZOLIDINE-2,4-DIONES FOR TREATMENT OF MEDICAL DISORDERS
#284Combination of unsaponifiable lipids combined with polyphenols and/or catechins for the protection, treatment and repair of cartilage in joints of humans and animals
#285Natural drugs for the treatment of inflammation and melanoma
#286Suppression of Cytokine Release and Cytokine Storm
#287Rapamycin 40-O-cyclic hydrocarbon esters, compositions and methods
#288Glycophospholipid polymeric network and use thereof
#289Compositions and methods for invasive and non-invasive procedural skincare
#290Composition and method for treating, relieving or preventing neuropathic pain, containing choline alfoscerate as active ingredient
#291Treating microvascular dysfunction
#292Method of administration and treatment
#293Stimulation of an immune response by enantiomers of cationic lipids
#294INHIBITORS
#295Combination of broadly neutralizing HIV antibodies and viral inducers
#296LIPOSOMES FOR TREATMENT OF AN AUTOIMMUNE DISEASE
#297NEUPANEX®: neuroprotective, neuroregenerational, and neurogenesis supporting supplement combination
#298Lipid supplements for reducing nerve action potentials
#299Compositions and methods for the treatment and prophylaxis of surgical site infections
#300Intelligent delivery of ingested and absorbed molecules